Skip to Content


Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.


Notice; correction.


The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Monday, August 27, 2012 (77 FR 51811). The document announced a draft guidance for industry entitled “Self-Identification of Generic Drug Facilities, Sites, and Organizations.” The document was published with an incorrect docket number. This document corrects that error.


Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.


In FR Doc. 2012-20946, appearing on page 51811 in the Federal Register of Monday, August 27, 2012, the following correction is made:

1. On page 51811, in the third column, the docket number is corrected to read “FDA-2012-D-0881”.

Dated: August 30, 2012.

Leslie Kux,

Assistant Commissioner for Policy.

[FR Doc. 2012-22784 Filed 9-14-12; 8:45 am]